UCSF

Tagged: diabetes

The Kidney Project and the bioartificial pancreas: When inspiration strikes twice

Inspiration can be a hard thing to find. The history of science is filled with elusive “eureka moments” taking place under unlikely circumstances—Archimedes’ jump in a bath to intuit displacement, Issac Newton’s observation of a falling apple to grasp gravity, and Nikola Tesla’s inspiration for the...

Tumor analysis, prediction of transplant complications, and management of blood potassium levels take top honors at annual seminar

The Gary Rifkind Awards recognize and celebrate clinical pharmacy research.

Update from the Dean – March 2018

A new PharmD curriculum; Implementing new practice opportunities for pharmacists; PharmD students shine in state and national clinical pharmacy competitions; A pioneer in pharmacogenomics; The NIH streak lives on; Improving adverse event reporting and medication therapy protocols; Big-data to cut...

Novel diabetes treatment developed in Desai Lab to power SF-area startup

A UC San Francisco-created, insulin-generating implant that utilizes nanotechnology is closer to becoming a real treatment for diabetes, after being acquired by a San Francisco-based startup.

Giacomini to receive North American Scientific Achievement Award

Kathy Giacomini, PhD, a leader in the field of pharmacogenomics, has been named the 2017 recipient of the North American Scientific Achievement Award, presented by the International Society for the Study of Xenobiotics (ISSX).

Giacomini honored with ASCPT Distinguished Service Award

Kathy Giacomini, PhD, has been named the 2017 recipient of the Henry W. Elliott Distinguished Service Award from the American Society for Clinical Pharmacology and Therapeutics (ASCPT).

Kroon named Fellow of the American Pharmacists Association

Lisa Kroon, PharmD, chair of the UCSF School of Pharmacy’s Department of Clinical Pharmacy, has been named a Fellow of the American Pharmacists Association Academy of Pharmacy Practice and Management (APhA-APPM).

Insulin-producing pancreatic cells created from human skin cells

Scientists at the Gladstone Institutes, the Diabetes Center at UCSF, and the UCSF School of Pharmacy have converted human skin cells into fully functional pancreatic cells that produce insulin in response to changes in glucose levels.

Roy receives JDRF funding to develop implants to treat type 1 diabetes

UCSF School of Pharmacy faculty member Shuvo Roy, PhD, has received a three-year $1 million grant to create surgically implantable capsules of donor pancreas cells to free type 1 diabetes patients from daily insulin injections and the disease’s potentially life-threatening complications.

Pages